Publication | Closed Access

DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis

Insulin ResistanceObesityMolecular PharmacologyMetabolic SyndromeNutritionMedicineDiabetesObesity ManagementPutative Pparγ AgonistGut DysbiosisMetabolismPharmacologyInsulin SignalingHealth Sciences